Krsnaa Diagnostics Stock Screener | Share Price & Fundamental Analysis
KRSNAA
Healthcare Service Provider
Screen Krsnaa Diagnostics share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹747.05
▲
13.70 (1.87%)
Share Price BSE
₹746.55
▲
11.45 (1.56%)
Market Cap
₹2,378.89 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.60
EPS (TTM)
₹23.04
Dividend Yield
0.37%
Debt to Equity
0.21
52W High
₹920.30
52W Low
₹634.10
Operating Margin
29.00%
Profit Margin
11.43%
Revenue (TTM)
₹210.00
EBITDA
₹63.00
Net Income
₹24.00
Total Assets
₹1,282.00
Total Equity
₹883.00
Krsnaa Diagnostics Share Price History - Stock Screener Chart
Screen KRSNAA historical share price movements with interactive charts. Analyze price trends and patterns.
Krsnaa Diagnostics Company Profile - Fundamental Screener
Screen Krsnaa Diagnostics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KRSNAA shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE08LI01020
Krsnaa Diagnostics Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen KRSNAA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 1,282 | 1,172 | 910 | 876 |
| Current Assets | 415 | 421 | 223 | 334 |
| Fixed Assets | 670 | 647 | 471 | 386 |
| Liabilities | ||||
| Total Liabilities | 1,282 | 1,172 | 910 | 876 |
| Current Liabilities | 93 | 81 | 72 | 71 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 883 | 810 | 739 | 684 |
| Share Capital | 16 | 16 | 16 | 16 |
| Reserves & Surplus | 867 | 794 | 723 | 669 |
Screen KRSNAA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 210 | 197 | 191 | 184 | 191 | 178 | 171 | 162 | 160 | 144 | 139 | 123 | 127 | 118 | 112 |
| Expenses | 147 | 142 | 133 | 129 | 137 | 128 | 123 | 121 | 124 | 108 | 99 | 89 | 92 | 85 | 80 |
| EBITDA | 63 | 55 | 57 | 54 | 54 | 50 | 48 | 42 | 36 | 36 | 40 | 34 | 35 | 32 | 32 |
| Operating Profit % | 29.00% | 27.00% | 28.00% | 26.00% | 27.00% | 25.00% | 26.00% | 24.00% | 20.00% | 22.00% | 26.00% | 25.00% | 25.00% | 25.00% | 26.00% |
| Depreciation | 24 | 22 | 22 | 23 | 22 | 22 | 18 | 21 | 20 | 16 | 15 | 14 | 13 | 12 | 10 |
| Interest | 8 | 6 | 7 | 6 | 6 | 5 | 7 | 4 | 3 | 2 | 2 | 2 | 2 | 1 | 2 |
| Profit Before Tax | 32 | 27 | 29 | 26 | 25 | 23 | 23 | 16 | 13 | 18 | 24 | 18 | 20 | 19 | 20 |
| Tax | 8 | 7 | 8 | 6 | 6 | 5 | 4 | 3 | 3 | 3 | 5 | 4 | 5 | 5 | 2 |
| Net Profit | 24 | 21 | 21 | 19 | 20 | 18 | 19 | 13 | 11 | 15 | 19 | 14 | 15 | 14 | 18 |
| EPS | 7.38 | 6.35 | 6.40 | 6.01 | 6.07 | 5.55 | 5.80 | 4.09 | 3.35 | 4.66 | 6.03 | 4.35 | 5.73 | 4.53 | 5.40 |
Krsnaa Diagnostics Cash Flow Screener - Liquidity Fundamentals
Screen KRSNAA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2024-March | 2023-March | 2022-March | 2017-March | 2016-March |
|---|---|---|---|---|---|
| Operating Activities | 24 | 76 | 128 | 64 | -23 |
| Investing Activities | -129 | -109 | -241 | -54 | -47 |
| Financing Activities | 84 | -33 | 176 | -41 | 105 |
| Net Cash Flow | -20 | -66 | 64 | -31 | 36 |
Screen KRSNAA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 27.24% | 27.11% | 27.11% | 27.03% | 27.17% | 27.17% | 27.24% | 27.80% |
| FII Holding | 3.55% | 3.40% | 3.67% | 3.34% | 3.33% | 3.63% | 4.04% | 0.00% |
| DII Holding | 14.26% | 14.24% | 14.96% | 15.37% | 15.26% | 15.86% | 14.46% | 18.49% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 29.13% | 28.95% | 27.40% | 27.72% | 28.73% | 28.41% | 29.11% | 21.80% |
| Other Holding | 25.81% | 26.30% | 26.86% | 26.54% | 25.51% | 24.94% | 25.16% | 31.91% |
| Shareholder Count | 53,559 | 54,262 | 52,117 | 56,458 | 55,914 | 53,519 | 52,799 | 67,116 |
Krsnaa Diagnostics Dividend Screener - Share Yield Analysis
Screen KRSNAA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.75 | 0.37% |
| 2024-March | ₹2.50 | 0.32% |
| 2023-March | ₹2.75 | 0.45% |
| 2022-March | ₹2.50 | 0.56% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Krsnaa Diagnostics Index Membership - Market Screener Classification
Screen KRSNAA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Krsnaa Diagnostics Market Events Screener - Corporate Actions
Screen KRSNAA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 2.75 /share | 19.09% | ||
| Dividend | ₹ 2.75 /share | 29.48% | ||
| Dividend | ₹ 2.50 /share | 30.88% | ||
| Annual General Meeting | NA | 34.63% | ||
| Dividend | ₹ 2.50 /share | -2.35% | ||
| Annual General Meeting | NA | -2.52% | ||
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -5.58% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | 1.65% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -0.88% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.27% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | -3.06% |
Krsnaa Diagnostics Competitors Screener - Peer Comparison
Screen KRSNAA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,700 | 46.83 | 2,555 | 11.28% | 492 | 51.43 |
| Vijaya Diagnostic Centre | 10,881 | 70.34 | 700 | 23.06% | 144 | 61.34 |
| Metropolis Healthcare | 10,019 | 61.96 | 1,346 | 10.64% | 146 | 53.04 |
| Thyrocare Technologies | 7,309 | 56.28 | 702 | 20.80% | 91 | 53.15 |
| Nephrocare Health Services | 4,760 | 68.04 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,379 | 28.37 | 743 | 16.70% | 78 | 46.09 |
| Suraksha Diagnostic | 1,441 | 45.66 | 256 | 15.11% | 31 | 45.86 |
| One Global Service Provider | 1,237 | 28.65 | 148 | 134.60% | 19 | 58.56 |
| 3B BlackBio DX | 1,214 | 24.67 | 112 | 28.72% | 48 | 56.43 |
| Sastasundar Ventures | 1,004 | -103.51 | 1,171 | -18.47% | -134 | 60.55 |
Krsnaa Diagnostics Company Announcements - News Screener
Screen KRSNAA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-30 | Closure of Trading Window | View |
| 2025-12-12 | Board Meeting Outcome for For Meeting Held On December 12 2025. | View |
| 2025-12-09 | Closure of Trading Window | View |
| 2025-12-09 | Board Meeting Intimation for Proposed Fund Raising. | View |
| 2025-12-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-10 | Submission Of Revised Investor Presentation. | View |
| 2025-11-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-07 | Results For Quarter And Half Year Ended September 30 2025. | View |
| 2025-11-07 | Board Meeting Outcome for For Meeting Held On November 07 2025. | View |
| 2025-10-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-29 | Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |